Volume 3, Issue 1 (March 2017)                   Curr Med Mycol 2017, 3(1): 25-29 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abastabar M, Akbari A, Akhtari J, Hedayati M T, Shokohi T, Mehrad-Majd H, et al . In vitro antitumor activity of patulin on cervical and colorectal cancer cell lines. Curr Med Mycol. 2017; 3 (1) :25-29
URL: http://cmm.mazums.ac.ir/article-1-151-en.html
Abstract:   (1739 Views)
Background and Purpose: Patulin is a mycotoxin produced by some molds,especially Aspergillus and Penicilium, and is responsible for mycotoxicosis in animals and humans.There is still not very detailed data about the anti-cancer potency of patulin, but some reports demonstrated that it induces cellular apoptosis and toxicity.
Materials and Methods: To determine the efficacy of patulin as a therapeutic strategy for cervical and colorectal cancers, we investigated its effects on HeLa,SW-48, and MRC-5 cell lines. Cell lines were exposed to various concentrations of patulin (i.e., 0.5, 1, 2, and 4 µM), then using methyl thiazolyl tetrazolium (MTT) and bromo-2′-deoxyuridine (BrdU) assays, the rates of apoptosis and cell viability were determined.
Results: The obtained results showed a significant reduction in cell viability and apoptosis induction in a dose-dependent manner. Among all the cell lines, the highest growth inhibition rate was obtained at the 4 μM concentration of patulin.Conclusion: Our results suggested that patulin could significantly decrease tumor growth in human cervical and colorectal cancer models.
Full-Text [PDF 882 kb]   (568 Downloads)    
Type of Study: Original Articles | Subject: Medical Mycology
Received: 2017/09/4 | Accepted: 2017/11/11 | Published: 2017/12/13

1. Harrison MA. Presence and stability of patulin in apple products: a review. J Food Saf. 1988; 9(3):147-53 [DOI:10.1111/j.1745-4565.1988.tb00515.x]
2. Wurgler, F.E.; Friederich, U.; Schlatter, J. Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonellatyphimurium TAI02. Mutat. Res. 1991, 261(3), 209–216. [DOI:10.1016/0165-1218(91)90069-X]
3. International Agency for Research on Cancer. Some naturally occurring and synthetic food components, furocoumarins and ultraviolet radiation. Geneva: World Health Organization; 1998 5- Reddy, C.S.; Chan, P.K.; Hayes, A.W. Teratogenic and dominant lethal studies of patulin in mice. Toxicology 1978, 11(3), 219–223.
4. Dailey R, Brouwer E, Blaschka A, Reynaldo E, Green S,Monlux W, et al. Intermediate‐duration toxicity study of patulin in rats. J Toxicol Environ Health. 1977; 2(3):713-25. [DOI:10.1080/15287397709529471]
5. Reddy, C.S.; Chan, P.K.; Hayes, A.W. Teratogenic and dominant lethal studies of patulin in mice. Toxicology 1978, 11(3), 219–223. [https://doi.org/10.1016/S0300-483X(78)91339-2]
6. Puel O, Galtier P, Oswald IP. Biosynthesis and toxicological effects of patulin. Toxins. 2010; 2(4):613-31. [DOI:10.3390/toxins2040613]
7. Akhtari J, Rezayat SM, Teymouri M, Alavizadeh SH,Gheybi F, Badiee A, et al. Targeting, bio distributive and tumor growth inhibiting characterization of antiHER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors. Int J Pharm. 2016; 505(1-2):89-95. [DOI:10.1016/j.ijpharm.2016.03.060]
8. Alavizadeh SH, Akhtari J, Badiee A, Golmohammadzadeh S, Jaafari MR. Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models. Expert Opin Drug Deliv. 2016; 13(3):325 -36. [DOI:10.1517/17425247.2016.1121987]
9. Liu BH, Wu TS, Yu FY, Wang CH. Mycotoxin patulin activates the p38 kinase and JNK signaling pathways in human embryonic kidney cells. Toxicol Sci. 2005;89(2):423-30. [DOI:10.1093/toxsci/kfj049]
10. Selmanoglu G, Koçkaya EA. Investigation of the effects of patulin on thyroid and testis, and hormone levels in growing male rats. Food Chem Toxicol.2004; 42(5):721-7. [DOI:10.1016/j.fct.2003.12.007]
11. Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, et al. Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst. 2015; 107(6):djv048. [DOI:10.1093/jnci/djv048]
12. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016; 66(1):7-30. [DOI:10.3322/caac.21332]
13. Ferrer E, Juan-García A, Font G, Ruiz M. Reactive oxygen species induced by beauvericin, patulin and zearalenone in CHO-K1 cells. Toxicol Vitro. 2009; 23(8):1504-9. [DOI:10.1016/j.tiv.2009.07.009]
14. Lehner B, Sandner B, Marschallinger J, Lehner C, Furtner T, Couillard-Despres S, et al. The dark side of BrdU in neural stem cell biology: detrimental effects on cell cycle, differentiation and survival. Cell Tissue Res. 2011; 345(3):313 -28. [DOI:10.1007/s00441-011-1213-7]
15. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014; 64(1):52-62. [DOI:10.3322/caac.21203]
16. Bosch FX. The path to eliminate cervical cancer in the world and the challenges of professional education. Vaccine. 2013; 31:7. [DOI:10.1016/j.vaccine.2013.10.008]
17. Nicolay NH, Berry DP, Sharma RA. Liver metastases from colorectal cancer: radioembolization with systemic therapy. Nat Rev Clin Oncol. 2009; 6(12):687-97. [DOI:10.1038/nrclinonc.2009.165]
18. Wiela-Hojeńska A, Kowalska T, Filipczyk-Cisarż E, Łapiński Ł, Nartowski K. Evaluation of the toxicity of anticancer chemotherapy in patients with colon cancer. Adv Clin Exp Med. 2015; 24(1):103-11. [DOI:10.17219/acem/38154]
19. Remesh A. Toxicities of anticancer drugs and its management. Int J Basic Clin Pharm. 2012; 1(1):2-12. [DOI:10.5455/2319-2003.ijbcp000812]
20. Guo X, Dong Y, Yin S, Zhao C, Huo Y, Fan L, et al. Patulin induces pro-survival functions via autophagy inhibition and p62 accumulation. Cell Death Dis. 2013; 4(10):e822. [DOI:10.1038/cddis.2013.349]
21. Alves I, Oliveira N, Laires A, Rodrigues A, Rueff J. Induction of micronuclei and chromosomal aberrations by the mycotoxin patulin in mammalian cells: role of ascorbic acid as a modulator of patulin clastogenicity. Mutagenesis. 2000; 15(3):229-34. [DOI:10.1093/mutage/15.3.229]
22. Burghardt RC, Barhoumi R, Lewis EH, Bailey RH, Pyle KA, Clement BA, et al. Patulin-induced cellular toxicity: a vital fluorescence study. Toxicol Appl Pharmacol. 1992; 112(2):235-44. [DOI:10.1016/0041-008X(92)90193-V]
23. Luft P, Oostingh GJ, Gruijthuijsen Y, Horejs‐Hoeck J,Lehmann I, Duschl A. Patulin influences the expression of Th1/Th2 cytokines by activated peripheral blood mononuclear cells and T cells through depletion of intracellular glutathione. Environ Toxicol. 2008;23(1):84-95. [DOI:10.1002/tox.20309]
24. Wu TS, Liao YC, Yu FY, Chang CH, Liu BH.Mechanism of patulin-induced apoptosis in human leukemia cells (HL 60). Toxicol Lett. 2008;183(1):105-11. [DOI:10.1016/j.toxlet.2008.09.018]
25. Nagashima H, Nakagawa H, Kushiro M, Iwashita K. The in vitro approach to the cytotoxicity of a trichothecene mycotoxin nivalenol. Japan Agricul Res Quart. 2009;43(1):7-11. [DOI:10.6090/jarq.43.7]
26. Mahdavian E, Palyok P, Adelmund S, Williams-Hart T,Furmanski BD, Kim YJ, et al. Biological activities of fusarochromanone: a potent anti-cancer agent. BMC Res Notes. 2014; 7(1):601. [DOI:10.1186/1756-0500-7-601]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2015 All Rights Reserved | Current Medical Mycology